Holen Sie sich die Stockscreener-App
0.6076
2.97%
-0.0186
Handel nachbörslich:
.61
0.0024
+0.39%
Bone Biologics Corp Aktie (BBLG) Neueste Nachrichten
Bone (BBLG) Chart: Finishes 3.47% Lower at $0.62 for the Current Session; the Price Remains Bounded by the Supplied Support and Resistance under the Current SnapshotVolume Climax - vinanet.vn
Bone (BBLG) Results and Estimates: The Bottom-Line Figure Outpaces Its Comparison in the Current Update; Post-Report Move: The Stock Ends Down 2.58% in the Latest SessionEPS Growth Report - vinanet.vn
Bone Biologics (NASDAQ: BBLG) seeks 1-for-2 to 1-for-10 reverse split approval - Stock Titan
Price to sales forward of Bone Biologics Corp – NASDAQ:BBLGW - TradingView
Number of shareholders of Bone Biologics Corp – NASDAQ:BBLGW - TradingView
Bone Biologics Corp (BBLG) Slips 2.86% as Shares Test Key Support at $0.63Systematic Flow - vinanet.vn
BBLGW Warrants Hold Flat at $7.05 as Bone Biologics Consolidates Between $6.7 and $7.4Volatility Breakout Picks - vinanet.vn
Bone Biologics Raises $2.7M, Extends Cash Runway to Q2 2027 - Minichart
12 Health Care Stocks Moving In Wednesday's After-Market Session - Benzinga
Bone Biologics Warrants (BBLGW) Hold at $3.50 as Traders Eye Tight RangeEquity Put Call - dars.gov.et
12 Health Care Stocks Moving In Wednesday's Intraday Session - Benzinga
Bone Biologics Extends rhNELL-1 Validated Shelf Life to 32 Months as NB1 Study Advances - Yahoo Finance
12 Health Care Stocks Moving In Wednesday's Pre-Market Session - Benzinga
Bone Biologics Corporation Achieves 32-Month Validated Shelf Life For rhNELL-1 - marketscreener.com
Bone Biologics Corp expected to post a loss of 39 cents a shareEarnings Preview - TradingView
BBLG Q1 2026 Earnings: Narrower-Than-Expected Loss of -$0.43, Though Shares Slip 5.67%Performance Review - vinanet.vn
Bone Biologics Corp (BBLG) Earnings Forecast: Future EPS & Revenue Growth Estimates - TradingKey
US: Halma sells NovaBone to Keensight-backed Isto Biologics for US$60m - Investors in Healthcare
Bone Biologics Warrants (BBLGW) Steady at $8.0 as Tight Trading Range Takes ShapeValue ETF - dars.gov.et
Isto Biologics strengthens its bone graft substitutes platform with the acquisition of NovaBone - Orthopedics This Week
Isto Biologics Acquires NovaBone | Press Release - ACCESS Newswire
Bone Biologics Warrants (BBLGW) Hold Flat at $8.00 as Range-Bound Trading PersistsMA Cross Alert - dars.gov.et
Bone Biologics (BBLG) Dips 3.23% to $0.85 — Shares Approach Key Support at $0.81Money Flow - vinanet.vn
Bone Biologics Corp Warrants (BBLGW) Hold Steady at $8.0 Amid Low Volume ConsolidationSell Signal Alerts - vinanet.vn
Bone Biologics Corp (BBLG) Revenue Breakdown: Business Segments, Regional Revenue & Profit Contribution - TradingKey
Bone Biologics Corp Warrants (BBLGW) Holds Steady at $8.0 as Consolidation Pattern EmergesMESA MA - po-news-eg.net
Bone Biologics Corp (BBLG) Dividends & Stock Splits: Historical Payouts and Event Timeline - TradingKey
Bone Biologics Corp SEC Filing (Jul 27, 2026) - Stock Titan
Bone Biologics Corp (BBLG) Cash Flow - TradingKey
Bone Biologics Corp (BBLG) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
Bone Biologics Corp (BBLG) Financial Health: Profitability & Balance Sheet Analysis - TradingKey
BBLG|Bone Biologics Corp|Price:1.070|Chg%:-0.010 - TradingKey
BBLG|Bone Biologics Corp|Price:1.010|Chg%:-0.060 - TradingKey
Bone Biologics Corp (BBLG) Nears Support as Selling Pressure PersistsRetail Driven Moves - dars.gov.et
Bone Biologics Corp Revenue Breakdown – NASDAQ:BBLGW - tradingview.com
TradingKey - TradingKey
BBLG Q1 2026 Earnings: Narrowed Loss Beats Estimates, But Stock DeclinesProfit Cycle Analysis - Vinanet
Bone Biologics Corp Revenue Breakdown – NASDAQ:BBLG - TradingView
Bone Biologics Corp (BBLG) Valuation: PE, PB & Fair Value Analysis - TradingKey
Bone Biologics raises $3.0M in July financing, extends rhNELL-1 shelf life to 29 months - TradingView
Bone Biologics (Nasdaq: BBLG) raises $3M, extends runway to 2027 - Stock Titan
Bone Biologics extends rhNELL-1 shelf life to 29 months - Stock Titan
Bone Biologics Issues Mid-Year Shareholder Update Highlighting Progress Across 2026 Priorities - The Manila Times
Bone Biologics Corp (BBLG) Q1 2026 Earnings: Narrower-than-Expected Loss Highlights Cost Discipline - dars.gov.et
Price to book forward of Bone Biologics Corp – NASDAQ:BBLG - TradingView
Price to sales forward of Bone Biologics Corp – NASDAQ:BBLG - TradingView
Bone Biologics Corp (BBLG) Q1 2026 Earnings: Narrower-than-expected loss fails to lift stockPre-Announcement Alert - vinanet.vn
Form S-3 Bone Biologics Corp For: 17 July - Investing.com India
Form S-3 Bone Biologics Corp For: 17 July By Investing.com - Investing.com Nigeria
Bone Biologics (NASDAQ: BBLG) registers 6.46M warrant shares for resale - Stock Titan
Bone Biologics Corporation Files Form 8-K with SEC: Company Details, Stock Info, and Contact Information (July 2026) - Minichart
Bone postpones 2026 annual meeting to Sept. 28, sets new record date Aug. 6 - TradingView
Bone Biologics (NASDAQ: BBLG) delays 2026 meeting to September 28 - Stock Titan
World Fiber Viable Bone MatrixMarket Analysis, Forecast, Size, Trends and Insights - IndexBox
Enterprise value to revenue forward of Bone Biologics Corp – NASDAQ:BBLG - TradingView
Enterprise value to EBITDA forward of Bone Biologics Corp – NASDAQ:BBLG - TradingView
Bone Biologics Corp (BBLG) Q1 2026 Earnings: Narrower Loss Surprises; Stock Holds SteadyEarnings Miss Streak - dars.gov.et
Price to sales forward of Bone Biologics Corp – BOATS:BBLGW - TradingView
Enterprise value to EBIT forward of Bone Biologics Corp – BOATS:BBLGW - TradingView
Enterprise value to revenue forward of Bone Biologics Corp – BOATS:BBLGW - TradingView
Orthobiologics Devices And Equipment Market Report 2026 Market Outlook Supported By A Forecast 8% CAGR - openPR.com
Bone Biologics Announces $9 Million Private Placement for Spine Fusion Innovation and Clinical Trials Funding 12 - Minichart
Bone Biologics Raises $2.7 Million in Private Placement; Adds $6 Million Upside From Warrants - TradingView
Bone Biologics (BBLG) raises $3M in private placement with up to $6M via warrants - Stock Titan
Bone Biologics Corp (BBLG) Edges Higher Amid Low Volume, Tests Key Resistance LevelsMonthly Profile - dars.gov.et
0.00%
3.22%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):